Skip to main content
CGTX filings

Corporate insider profile

John Brendan Doyle Filing Activity

Latest reported as Chief Financial Officer of COGNITION THERAPEUTICS INC (CGTX).

Purchase filings
1
Reported companies
1
Net open-market value
$11,300
Latest transaction
Apr 16, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 16, 2026COGNITION THERAPEUTICS INC (CGTX)Chief Financial OfficerOpen Market Purchase10,000$1.13$11,300